title: [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
authors.forename: A
authors.initials: A
authors.lastname: García-Jiménez
authors.forename: P
authors.initials: P
authors.lastname: Iriarte Sotés
authors.forename: C J
authors.initials: CJ
authors.lastname: Fernández González
authors.forename: A
authors.initials: A
authors.lastname: Garrote Freire
authors.forename: J
authors.initials: J
authors.lastname: González Tutor
mesh_terms: D000368:Aged; D000402:Airway Obstruction / Q000139:chemically induced* / Q000188:drug therapy; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator